Cargando…
Cytoreductive Surgery and Normothermic Intraperitoneal Chemotherapy for Signet Ring Cell Appendiceal Adenocarcinoma With Peritoneal Metastases in the Setting of Cirrhosis
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are combined to treat peritoneal surface malignancies (PSM). The objective of cytoreduction is to eradicate macroscopic disease, while HIPEC addresses residual microscopic disease. Currently, there are no protocols gui...
Autores principales: | Panuganti, Bharat, Chang, Ea-sle, Helm, Cyril W., Schwartz, Theresa, Hsueh, Eddy C., Piao, Jinhua, Lai, Jinping, Veerapong, Jula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997481/ https://www.ncbi.nlm.nih.gov/pubmed/29915638 http://dx.doi.org/10.14740/gr1029w |
Ejemplares similares
-
Preoperative bevacizumab does not increase complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: King, Bradley H., et al.
Publicado: (2020) -
Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a prospective clinical trial and comparative analysis
por: Cho, Chae Yun, et al.
Publicado: (2022) -
Repeat cytoreductive surgery with or without intraperitoneal chemotherapy for recurrent epithelial appendiceal neoplasms
por: Karpes, J. B., et al.
Publicado: (2020) -
Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for perforated low-grade appendiceal mucinous neoplasms
por: Abudeeb, Haytham, et al.
Publicado: (2020) -
Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin: A Single Center Experience
por: Santullo, Francesco, et al.
Publicado: (2021)